[HTML][HTML] Proteochemometrics–recent developments in bioactivity and selectivity modeling
BJ Bongers, AP IJzerman, GJP Van Westen - Drug Discovery Today …, 2019 - Elsevier
Proteochemometrics is a machine learning based modeling approach relying on a
combination of ligand and protein descriptors. With ongoing developments in machine …
combination of ligand and protein descriptors. With ongoing developments in machine …
Sequence-based prediction of protein binding regions and drug–target interactions
Identifying drug–target interactions (DTIs) is important for drug discovery. However,
searching all drug–target spaces poses a major bottleneck. Therefore, recently many deep …
searching all drug–target spaces poses a major bottleneck. Therefore, recently many deep …
Structural insights into the origin of phosphoinositide 3-kinase inhibition
Class I phosphoinositide 3-kinases (PI3Ks) are currently considered as significant targets for
the development of novel pharmaceuticals to treat cancers and inflammatory diseases …
the development of novel pharmaceuticals to treat cancers and inflammatory diseases …
Prediction of viral protease inhibitors using proteochemometrics approach
DA Karasev, BN Sobolev, DA Filimonov… - … Biology and Chemistry, 2024 - Elsevier
Being widely accepted tools in computational drug search, the (Q) SAR methods have
limitations related to data incompleteness. The proteochemometrics (PCM) approach …
limitations related to data incompleteness. The proteochemometrics (PCM) approach …
3D proteochemometrics: using three-dimensional information of proteins and ligands to address aspects of the selectivity of serine proteases
V Subramanian, QU Ain, H Henno, LO Pietilä… - …, 2017 - pubs.rsc.org
The high similarity between certain sub-pockets of serine proteases may lead to low
selectivity of protease inhibitors. Therefore the application of proteochemometrics (PCM) …
selectivity of protease inhibitors. Therefore the application of proteochemometrics (PCM) …
Exploring the origin of phosphodiesterase inhibition via proteochemometric modeling
The phosphodiesterase (PDE) superfamily, including all PDE families and subfamilies, are
often implicated in diverse physiological disorders thereby making their selective inhibition …
often implicated in diverse physiological disorders thereby making their selective inhibition …
Probing the origin of dihydrofolate reductase inhibition via proteochemometric modeling
S Hariri, JB Ghasemi, F Shirini… - Journal of …, 2019 - Wiley Online Library
Dihydrofolate reductase (DHFR) is an essential enzyme in the folate metabolism pathway
and an important target of antineoplastic, antimicrobial, antiprotozoal, and antiinflammatory …
and an important target of antineoplastic, antimicrobial, antiprotozoal, and antiinflammatory …
Proteochemometric modeling of the interaction space of carbonic anhydrase and its inhibitors: an assessment of structure‐based and sequence‐based descriptors
B Rasti, M Namazi, MH Karimi‐Jafari… - Molecular …, 2017 - Wiley Online Library
Due to its physiological and clinical roles, carbonic anhydrase (CA) is one of the most
interesting case studies. There are different classes of CAinhibitors including sulfonamides …
interesting case studies. There are different classes of CAinhibitors including sulfonamides …
A novel proteochemometrics model for predicting the inhibition of nine carbonic anhydrase isoforms based on supervised Laplacian score and k-nearest neighbour …
E Nazarshodeh, R Sheikhpour… - SAR and QSAR in …, 2018 - Taylor & Francis
Carbonic anhydrases (CAs) are essential enzymes in biological processes. Prediction of the
activity of compounds towards CA isoforms could be evaluated by computational techniques …
activity of compounds towards CA isoforms could be evaluated by computational techniques …
Proteochemometric modeling of the origin of thymidylate synthase inhibition
B Rasti, SS Shahangian - Chemical Biology & Drug Design, 2018 - Wiley Online Library
Due to its crucial role in DNA synthesis, thymidylate synthase (TS) has been considered as a
potential therapeutic target. Inhibition of the enzyme is a promising strategy for the treatment …
potential therapeutic target. Inhibition of the enzyme is a promising strategy for the treatment …